Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Soins Gerontol ; 26(148): 24-25, 2021.
Article Fr | MEDLINE | ID: mdl-33894910

The Alzheimer's plans have led to significant progress in the care management of elderly people suffering from Alzheimer's disease or other forms of dementia, but the medical and social network remains fragmented in geriatrics. We have proposed to caregivers a monthly videoconference combining expert presentations and discussion of clinical cases. Several health professions were represented. The main positive point was the time saved. The videoconferencing improved multidisciplinary exchanges, especially for patients with complex problems and their families.


Alzheimer Disease , Geriatrics , Aged , Caregivers , Geriatric Psychiatry , Humans , Videoconferencing
2.
Support Care Cancer ; 29(2): 563-571, 2021 Feb.
Article En | MEDLINE | ID: mdl-32870413

INTRODUCTION: Depression symptoms, frequently diagnosed in older patients with cancer, impacts on oncological treatment feasibility. The Francophone Society of Geriatric Oncology (SOFOG) has initiated a systematic review on depression treatment in older patients with cancer, to advocate guidelines. DATA SOURCES: Medline via PubMed, Embase, CENTRAL. METHODS: We included randomized and non-randomized controlled trials, reviews and meta-analysis, retrospective and prospective cohort studies, qualitative studies, and guidelines published between January 2013 and December 2018 that involved depression with cancer in which the entire sample or a sub-group aged 65 and above. Efficacy and tolerance of depression treatment were examined, as a primary or secondary outcome, among articles published in French or English. RESULTS: Of 3171 references, only seven studies met our eligibility criteria. This systematic review reveals a lack of evidence-based knowledge in this field, preventing from making any recommendations on drug and non-drug therapies. It has highlighted the need for multidisciplinary collaboration with the French and Francophone Society of Psycho-Oncology. CONCLUSION: In clinical practice, we advise health professionals to use the screening process not as a result but rather as an opportunity to engage with the patient and also to question the need for antidepressants and non-drug therapies.


Depression/etiology , Depression/therapy , Depressive Disorder, Major/etiology , Depressive Disorder, Major/therapy , Neoplasms/psychology , Age Factors , Aged , Antidepressive Agents/therapeutic use , Depression/diagnosis , Depressive Disorder, Major/diagnosis , Humans , Meta-Analysis as Topic , Prospective Studies , Randomized Controlled Trials as Topic , Retrospective Studies
3.
Fundam Clin Pharmacol ; 34(4): 515-517, 2020 Aug.
Article En | MEDLINE | ID: mdl-31912909

Midazolam is a short-acting benzodiazepine approved for sedation and anesthesia induction. Recent data suggested that midazolam may also be used in off-label indications such as treatment of behavioral and psychological disturbances in older people. Given the scarcity of published data and a lack of evidence in older people in such indications, midazolam raises concern because it may also cause serious-related adverse events. To provide a better understanding of its real-life use in geriatrics, we examined the prescribing practices of midazolam in French older inpatients. Of the 460 patients aged 65 years and over hospitalized at the time of the study, 21 had a prescription of midazolam (5%) which was mainly prescribed for anxiolysis (n = 12), premedication before painful procedures (n = 5), and agitation (n = 4). Midazolam was often prescribed "as required," and the median duration of prescription was 6 months. This work results in a better knowledge and information about the use of midazolam in older people. These prescribing practices, which are not anecdotal, also plead for age-specific guidelines for the treatment of behavioral and psychological disturbances.


Analgesics/therapeutic use , Anti-Anxiety Agents/therapeutic use , Geriatrics , Inpatients , Midazolam/therapeutic use , Off-Label Use , Aged , Aged, 80 and over , Analgesics/adverse effects , Anesthetics/therapeutic use , Anti-Anxiety Agents/adverse effects , Drug Prescriptions , Drug Utilization , Female , France , Humans , Hypnotics and Sedatives/therapeutic use , Male , Midazolam/adverse effects , Practice Patterns, Physicians'
4.
Can J Aging ; 38(1): 90-99, 2019 03.
Article En | MEDLINE | ID: mdl-30404681

ABSTRACTWe aimed to understand clinical decision-making processes that influence the orientation of older patients after hospital discharge. We compared discharge decisions (i.e., discharge home, or nursing home stay) of the hospital team with those of an expert panel. Both panel and hospital team made their decisions independently. The blind study included 102 patients (mean age: 83.13 ± 6.74). There is a statistically significant difference between expert and hospital team decisions (p < .001; kappa coefficient: 0.468). Panel decisions were more closely associated with isolation (p = .018), reliable caregivers (p = .004), social problems (p = .001), and behavioural symptoms perceived as aggressive (p = .001). Both decision processes considered refusal of care (p = 0,025 and 0.016 respectively) and social problems (p = .001 and < 0.001 respectively). Discharge planning models differ depending on the country, team and patient's condition. Our study suggests more precise evaluation of patients' needs.


Clinical Decision-Making , Geriatric Assessment , Patient Discharge , Referral and Consultation/organization & administration , Aged , Aged, 80 and over , Female , Humans , Male , Outcome Assessment, Health Care , Retrospective Studies , Single-Blind Method , Socioeconomic Factors
5.
J Geriatr Psychiatry Neurol ; 27(2): 85-93, 2014 Jun.
Article En | MEDLINE | ID: mdl-24578460

OBJECTIVE: To examine the diagnostic ability of the Lawton Instrumental Activities Daily Living (IADLs) scale and the Activities Daily Living (ADLs) scale as a sensitive tool to Alzheimer's disease (AD) in community-dwelling elderly people. DESIGN: In an old age memory outpatient center, among patients with a clinical diagnosis of AD dementia or no dementia supported by at least 6 months of follow-up, we looked back at the baseline Lawton IADL scale (short version IADL-4 item), ADL scale, Mini-Mental State Examination (MMSE), and Montreal Cognitive Assessment (MOCA) values. RESULTS: There were 109 patients with AD and 53 nondemented individuals (81.4 ± 4.6 years). The sensitivity of ADL scale or IADL-4 item or the MMSE was low (52%-57%). The most efficient AD classification used both the IADLs-4 item and the MOCA with a threshold score of 20. Besides age and memory scores, the main correlates of IADLs scale or ADLs scale were executive, neuropsychiatric, vascular, and extrapyramidal scores. CONCLUSION: Our results suggest that the Lawton IADLs-4 item scale and ADLs scale lack sensitivity to AD dementia in elderly people and support a better sensitivity of MOCA rather than MMSE and IADLs-4 item/ADLs at the expense of specificity.


Alzheimer Disease/diagnosis , Dementia/diagnosis , Surveys and Questionnaires/standards , Activities of Daily Living , Aged , Aged, 80 and over , Alzheimer Disease/psychology , Dementia/psychology , Female , Follow-Up Studies , Humans , Male , Memory , Neuropsychological Tests , Reproducibility of Results , Sensitivity and Specificity
...